MabGenesis

Yokohama, Japan · Founded 2019 · Privately Held (backing)

Operator of a biopharmaceutical company intended to develop therapeutic monoclonal antibody drugs for humans and animals. MabGenesis is based in Yokohama, Japan and was founded in 2019. Its last reported valuation was $18.6 million in Dec 2024. It has raised $8.8 million.

Last reported valuation

$18.6M

Oct 2026

Priced at

—

Total raised

$8.8M

Last round

—

How much has MabGenesis raised?

$8.8Macross 0 recorded rounds

Free account

More of MabGenesis with a free account

·Watch MabGenesis: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

MabGenesis investors

9 investors are on record for MabGenesis, including SMBC Venture Capital, Beyond Next Ventures, Regional Economy Vitalization Corporation of Japan and REVIC Capital.

For fundraisers

Raising for a company like MabGenesis?

9 investors have backed MabGenesis.

See all 9 investors →

Frequently asked about MabGenesis

How much has MabGenesis raised?: MabGenesis has raised $8.8M in total across 0 recorded funding rounds.